Neuropeptide Y a novel angiogenic factor from the sympathetic nerves and endothelium

Circulation Research

Volumn 83, Issue 2, 1998, Pages 187-195

  Zukowska Grojec, Zofia ^a   Karwatowska Prokopczuk, Ewa ^a   Rose, Wesley ^c   Rone, Janice ^a   Movafagh, Sharareh ^a   Ji, Hong ^a   Yeh, Yunyun ^a   Chen, Wen Tien ^a   Kleinman, Hynda K ^b   Grouzmann, Eric ^d   Grant, Derrick S ^c  

^a GEORGETOWN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Angiogenesis; Chemotaxis; Dipeptidyl peptidase IV; Endothelial cell; NPY receptor

Indexed keywords

ANGIOGENIC FACTOR; DIPEPTIDYL PEPTIDASE IV; MATRIGEL; MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; ISCHEMIA; MALE; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; SYMPATHETIC NERVE; TISSUE REPAIR; VASOCONSTRICTION;

EID: 0032572596     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.2.187     Document Type: Article

References (42)

1. Klagsbrun M, Folkman J. Angiogenesis. In: Sporn MB, Roberts AB, eds. Peptide Growth Factors and Their Receptors. Berlin, Germany: Springer-Verlag; 1990:549-586.
2. Rakusan K. Coronary angiogenesis: from morphometry to molecular biology and back. Ann N Y Acad Sci. 1995;752:257-266.
3. Kubota Y, Kleinman HK, Martin GR, Lawley TJ. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol. 1988;107: 1589-1598.
4. Grant DS, Lelkes P, Martin GR, Kleinman HK. Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. Cell Dev Biol. 1991;21A:327-336.
5. Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci. 1997;22:251-256.
6. Blaes RD, Boissel JP. Growth-promoting effects of catecholamines on rat aortic smooth muscle cells in culture. J Cell Physiol. 1983;116:167-172.
7. Zukowska-Grojec Z, Pruszczyk P, Colton C, Yao J, Shen GH, Myers AK, Wahlestedt C. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides. 1993;14:263-268.
8. Bell L, Madri J. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ Res. 1989;65: 1057-1065.
9. Okazaki M, Hu Z-W, Fujinaga M, Hoffman BB. Alpha-1 adrenergic receptor- induced c-fos gene expression in rat aorta and cultured vascular smooth muscle cells. J Clin Invest. 1994;94:210-218.
10. Zukowska-Grojec Z, Wahlestedt C. Origin and actions of neuropeptide Y in the cardiovascular system. In: Colmers WF, Wahlestedt C, eds. The Biology of Neuropeptide Y and Related Peptides. Totowa, NJ: Humana Press; 1993:315-388.
11. Bumstock G. Integration of factors controlling vascular tone. Anesthesiology. 1993;79:1368-1380.
12. Myers AK, Farhat MY, Vaz CA, Keiser HR, Zukowska-Grojec Z. Release of immunoreactive neuropeptide Y by rat platelets. Biochem Biophys Res Commun. 1988;155:118-122.
13. Hassal CJ, Loesch A, Maynard KI, Burnstock G. Calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in endothelial cells after long term stimulation of perivascular nerves. Neuroscience. 1992; 48:723-726.
14. Zukowska-Grojee Z, Dayao EK, Karwatowska-Prokopczuk E, Hauser GJ, Doods HN. Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors. Am J Physiol. 1996;270: H796-H800.
15. Lundberg JM, Martinsson A, Hemsen A, Theordorsson-Norheim E, Svedenhag J, Ekblom B, Hjemdahl P. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun. 1985;133:30-34.
16. Franco-Cereceda A, Owall A, Settergren G, Sollevi A, Lundberg JM. Release of neuropeptide Y and noradrenaline from the human heart after aortic occlusion during coronary artery surgery. Cardiovasc Res. 1990; 24:241-246.
17. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vayesse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 1996;382:168-171.
18. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Fisher T, Ji H. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul Pept. In press.
19. Grundemar L. Multiple receptors and multiple actions. In: Grundemar L, Bloom SR, eds. Neuropeptide Y and Drug Development. San Diego, Calif: Academic Press; 1997:1-14.
20. Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H, Wahlestedt C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem. 1992;267:10935-10938.
21. Rose PM, Femandez P, Lynch JS, Frazier ST, Fischer SM, Kodukula K, Kienzle B, Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem. 1995; 270:22661-22664.
22. Bard JA, Walker MW, Branchek TA, Weinshank RL. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J Biol Chem. 1995;270: 26762-26765.
23. Weinberg DH, Sirinathsinghji DJS, Tan CP, Shiao L-L, Morin N, Rigby MR, Heavens RH, Rapoport DR, Bayne ML, Cascieri MA, Strader CD, Linemeyer DL, MacNeil DJ. Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem. 1996;271:16435-16438.
24. Mentlein R, Dahms P, Grandt D, Kruger R. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pept. 1993;49:133-144.
25. Johnson R, Zhu D, Augustin-Voss H, Pauli B. Lung endothelial dipeptidyl peptidase IV is an adhesion molecule for lung-metastatic rat breast and prostate carcinoma cells. J Cell Biol. 1993;121:1423-1432.
26. Kim W, Schnaper H, Nomizu M, Yamada Y, Kleinman H. Apoptosis in human fibrosarcoma cells is induced by a multimeric synthetic Tyr-Ile-Gly-Ser-Arg (YIGSR)-containing polypeptide from laminin. Cancer Res. 1994;54:5005-5010.
27. Grant DS, Kinsella JL, Piasecki BA, Yamada Y, Zain M, Freedman R, Kleinman HK. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J Cell Physiol. 1992;153:614-625.
28. Grant DS, Tashiro K-I, Segui-Real B, Yamada Y, Martin GR, Kleinman HK. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell. 1989;58: 933-943.
29. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest. 1992;1992: 519-528.
30. D'Amato RJ, Longhnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A. 1994;91:4082-4089.
31. Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta: a quantitative assay of angiogenesis in vitro. Lab Invest. 1990;63:115-122.
32. Sambrook J, Friesch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. New York, NY: Cold Spring Harbor; 1989.
33. Higuchi H, Yang H-YT, Sabol SL. Rat neuropeptide Y precursor gene expression. J Biol Chem. 1988;263:6288-6295.
34. Grouzmann E, Buclin T, Martire M, Cannizzaro C, Dorner B, Razaname A, Mutter M. Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor. J Biol Chem. 1997;272:7699-7706.
35. Rudolf K, Eberlein W, Engel W, Wieland HA, Willim KD, Entzeroth M, Wienen W, Beck-Sickinger AG, Doods HN. The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur J Pharmacol. 1994;271:R11-R13.
36. Zorn NE, Weill CL, Russell DH. The HIV protein, gp120, activates nuclear protein kinase C in nuclei from lymphocytes and brain. Biochem Biophys Res Commun. 1990;166:1133-1139.
37. Taub DD, Oppenheim JJ. Chemokines, inflammation and the immune system. Ther Immunol. 1994;1:229-246.
38. De La Fuente M, Bernaez I, Del Rio M, Hernanz A. Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY: involvement of protein kinase C. Immunology. 1993;80:259-265.
39. Kim J, Karwatowska-Prokopczuk E, Ji H, Movafagh S, Wesely L, Zukowska-Grojec Z. Multiple receptors and protease activity determine neuropeptide Y (NPY) growth factor and chemotactic actions [abstract]. Circulation. 1997;96(suppl I):I-354.
40. Lundberg JM, Hemsen A, Fried G, Theodorsson-Norheim E, Lagerkrantz C. Co-release of neuropeptide Y (NPY)-like immunoreactivity and catecholamines in newborn infants. Acta Physiol Scand. 1986;126:471-473.
41. Myers AK, Abi-Younes S, Zukowska-Grojec Z. Re-evaluation of the effects of neuropeptide Y on aggregation of human platelets. Life Sci. 1991;49:545-551.
42. Roder C, Schwarzer C, Vezzani A, Gobbi M, Mennini T, Sperk G. Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures. Neuroscience. 1996;70:47-55.